Trends in Coronary Revascularization and Ischemic Heart Disease-Related Mortality in Israel

Orit Blumenfeld1, Wasef Na'amnih2, Ayelet Shapira-Daniels3

  • 1Israel Centers for Disease Control, Ministry of Health, Ramat Gan, Israel orit.blumenfeld@moh.health.gov.il.

Insights

Percutaneous coronary angioplasty (PCI) volume initially rose then fell, while coronary artery bypass grafting (CABG) significantly declined in Israel. Despite these shifts, procedural mortality remained stable, and ischemic heart disease mortality decreased substantially.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Investigated national trends in coronary revascularization procedures and ischemic heart disease mortality in Israel.
  • Examined percutaneous coronary angioplasty (PCI) and coronary artery bypass grafting (CABG) volumes and outcomes.
  • Assessed ischemic heart disease-related mortality rates.

Purpose of the Study:

  • To analyze national trends in the volume and outcomes of PCI and CABG in Israel from 2002 to 2014.
  • To evaluate changes in procedural mortality and ischemic heart disease-related mortality over the study period.
  • To identify shifts in the utilization of different revascularization strategies.

Main Methods:

  • Linked five Israeli national databases, including specialized PCI and CABG registries.
  • Utilized International Classification of Diseases codes for data extraction.
  • Analyzed trends using linear regression with a Poisson distribution assumption.

Main Results:

  • Total revascularization procedures exceeded 298,000.
  • PCI volume increased initially then decreased; CABG volume saw a significant decline of 59%.
  • In-hospital procedural mortality remained stable for both PCI and CABG, while ischemic heart disease mortality decreased by 46%.

Conclusions:

  • Observed a significant shift in the type and volume of coronary revascularization procedures in Israel.
  • Noted a substantial reduction in ischemic heart disease-related mortality.
  • The underlying reasons for these observed changes require further investigation.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...